Screening for antibodies in narcolepsy type 1 and type 2 by Giannoccaro, M, Waters, P, Pizza, F, Liguori, R, Plazzi, G, Vincent, A

Antibodies against hypocretin receptor 2 are rare in narcolepsy by Giannoccaro, M, Waters, P, Pizza, F, Liguori, R, Plazzi, G, Vincent, A

Human hypocretin receptor 2 antibodies are rare in idiopathic narcolepsy by Giannoccaro, M, Waters, P, Pizza, F, Liguori, R, Plazzi, G, Vincent, A

Behaviour and neuropathology in mice injected with human contactin- associated protein 2 antibodies by Giannoccaro, M, Menassa, D, Jacobson, L, Coutinho, E, Prota, G, Lang, B, Leite, M, Cerundolo, V, Liguori, R, Vincent, A

Immune or genetic-mediated disruption of CASPR2 causes pain hypersensitivity due to enhanced primary afferent excitability by Dawes, J, Weir, G, Middleton, S, Patel, R, Chrisholm, K, Pettingill, P, Peck, L, Sheridan, J, Shakir, A, Jacobson, L, Gutierrez-Mecinas, M, Galino, J, Walcher, J, Kuhnemund, J, Kuehn, H, >Sanna, M, Lang, B, Clark, A, Themistocleous, A, Iwagaki, N, West, S, Werynska, K, Carroll, L, Trendafiolva, T, Menassa, D, Giannoccaro, M, Coutinho, E, Cervellini, I, Tewari, D, Buckley, C, Leite, M, Wildner, H, Zeilhofer, H, Peles, E, Todd, A, McMahon, S, Dickenson, A, Lewin, G, Vincent, A, Bennett, D